[1]鲁俊山,房彩平,高竟,等.牛膝温经汤治疗寒湿痹阻型膝骨关节炎的临床研究[J].中国中医骨伤科杂志,2026,34(02):58-63.[doi:10.20085/j.cnki.issn1005-0205.260209]
 LU Junshan,FANG Caiping,GAO Jing,et al.Clinical Study on Niuxi Wenjing Decoction in the Treatment of Knee Osteoarthritis with Cold-Dampness Obstruction Syndrome[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2026,34(02):58-63.[doi:10.20085/j.cnki.issn1005-0205.260209]
点击复制

牛膝温经汤治疗寒湿痹阻型膝骨关节炎的临床研究()

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第34卷
期数:
2026年02期
页码:
58-63
栏目:
临床研究
出版日期:
2026-02-15

文章信息/Info

Title:
Clinical Study on Niuxi Wenjing Decoction in the Treatment of Knee Osteoarthritis with Cold-Dampness Obstruction Syndrome
文章编号:
1005-0205(2026)02-0058-06
作者:
鲁俊山1房彩平1高竟1陶帅1△
1泰州市中医院(江苏 泰州,225300)
Author(s):
LU Junshan1FANG Caiping1GAO Jing1TAO Shuai1△
1Taizhou Hospital of Traditional Chinese Medicine,Taizhou 225300,Jiangsu China.
关键词:
膝骨关节炎 牛膝温经汤 寒湿痹阻
Keywords:
knee osteoarthritis Niuxi Wenjing decoction cold-dampness obstruction
分类号:
R684.3
DOI:
10.20085/j.cnki.issn1005-0205.260209
文献标志码:
A
摘要:
目的:探讨牛膝温经汤治疗寒湿痹阻型膝骨关节炎的临床疗效。方法:选取80例寒湿痹阻型膝骨关节炎患者,通过随机数字表法分为观察组和对照组(各40例)。对照组口服塞来昔布胶囊,0.2 g/次,2次/d; 观察组口服牛膝温经汤,1剂/d,分2次温服。4周后观察两组患者VAS评分、中医证候评分、WOMAC评分、肌骨超声下滑膜评价及血清炎症因子IL-1β、TNF-α治疗后的变化。结果:两组患者各观察指标治疗前比较,差异无统计学意义(P>0.05); 治疗后各观察指标评分较其治疗前明显降低,差异有统计学意义(P<0.01); 治疗后与对照组比较,观察组患者中医证候评分及WOMAC评分下降,差异有统计学意义(P<0.01)。结论:牛膝温经汤治疗寒湿痹阻型膝骨关节炎疗效满意,其机制可能与炎症因子IL-1β、TNF-α的降低有关。
Abstract:
Objective:To discuss the clinical efficacy of Niuxi Wenjing decoction in the treatment of knee osteoarthritis(KOA)with cold-dampness obstruction syndrome.Methods:Eighty patients with KOA and cold-dampness obstruction were randomly divided into observation group and control group with 40 cases in each group by using random number table method.The control group received oral celecoxib capsules,0.2 g each times,twice daily,whereas the observation group was given oral Niuxi Wenjing decoction,1 dose per day,taken warmly twice a day.Both treatments were given for 4 weeks.The changes in VAS scores,TCM symptom scores,WOMAC scores,musculoskeletal ultrasound assessments,and serum levels of IL-1β and TNF-α were observed before and after treatment.Results:No statistically significant differences were observed in any of observation indicators between the two groups before treatment(P>0.05).After treatment,significant decreases were found in all observation indicators within each group compared to their respective baseline levels(P<0.01).Compared with the control group,the observation group showed lower scores after treatment for both TCM syndrome assessment and WOMAC scores(P<0.01).Conclusion:Niuxi Wenjing decoction shows significant efficacy in the treatment of KOA with cold-dampness obstruction.The mechanism may be associated with the reduction of inflammatory factors(IL-1β,TNF-α).

参考文献/References:

[1] 葛炎,田松云,刘鑫鑫,等.膝舒方防治阳虚寒凝型膝骨关节炎的实验研究[J].中国中医骨伤科杂志,2024,32(7):18-23.
[2] 王玉文,朱民顺,梁龙,等.浮针疗法联合塞来昔布胶囊口服治疗早中期膝骨关节炎[J].中医正骨,2025,37(1):76-78.
[3] 林如意,孙定炯,叶锐,等.温针灸治疗膝关节骨关节炎的效果及对OPG、MMP-3水平的影响[J].中华中医药学刊,2019,37(6):1485-1487.
[4] BRILLIANT Z R,GARVEY M D,HAFFNER R,et al.Unicompartmental knee arthroplasty patients have lower joint awareness and higher function at 5 years compared to total knee arthroplasties:a matched comparison[J].The Journal of Arthroplasty,2023,38(8):1464-1469.
[5] SRINIVASAN V,ETHIRAJ P,AGARAWAL S,et al.Comparison of various modalities in the treatment of early knee osteoarthritis:an unsolved controversy[J].Cureus,2023,15(1):e33630.
[6] 康俊峰,揭立士,廖太阳,等.膝痹宁Ⅱ治疗寒湿痹阻型膝骨关节炎的随机对照研究[J].中国中医骨伤科杂志,2025,33(1):27-32.
[7] 中华中医药学会.膝骨关节炎中西医结合诊疗指南(2023年版)[J].中医正骨,2023,35(6):1-10.
[8] 中国中医药研究促进会骨伤科分会.膝骨关节炎中医诊疗指南(2020年版)[J].中医正骨,2020,32(10):1-14.
[9] 中华医学会骨科学分会关节外科学组.骨关节炎诊疗指南(2018年版)[J].中华骨科杂志,2018,38(12):705-715.
[10] MCALINDON T,ZUCKER N V,ZUCKER M O.2007 OARSI recommendations for the management of hip and knee osteoarthritis:towards consensus?[J].Osteoarthritis and Cartilage,2008,16(6):636-637.
[11] PRICE D D,MCGRATH P A,RAFII A,et al.The validation of visual analogue scales as ratio scale measures for chronic and experimental pain[J].Pain,1983,17(1):45-56.
[12] BELLAMY N,BUCHANAN W W,GOLDSMITH C H,et al.Validation study of WOMAC:a health status instrument for measuring clinically-important patient-relevant outcomes following total hip or knee arthroplasty in osteoarthritis[J].Journal of Rheumatology,1988,15(12):1833-1840.
[13] 阎小萍.常见风湿病诊治手册[M].北京:中国医药科技出版社,2011:174.
[14] WALTHER M,HARMS H,KRENN V,et al.Correlation of power Doppler sonography with vascularity of the synovial tissue of the knee joint in patients with osteoarthritis and rheumatoid arthritis[J].Arthritis & Rheumatism,2001,44(2):331-338.
[15] IAGNOCCO A,EPIS O,SEDIE A D,et al.Ultrasound imaging for the rheumatologist.XVII.Role of colour Doppler and power Doppler[J].Clinical & Experimental Rheumatology,2008,26(5):759-762.
[16] 陈鹏宇,叶超,赵久丽,等.膝骨关节炎不同证候患者关节液白介素-1β浓度特点研究[J].中国中医骨伤科杂志,2024,32(9):26-30.
[17] 黄佳颖,刘世敏,陆晔庆,等.温针灸联合中药热敷治疗膝骨关节炎寒湿痹阻证[J].中医正骨,2024,36(6):58-60.
[18] 尚娟,王德贞.独活寄生汤结合雷火灸治疗膝骨性关节炎风寒湿痹阻证的疗效及对炎症反应、氧化应激的影响[J].辽宁中医杂志,2023,50(8):150-153.
[19] 蔡晓路,谢晴宇,孟庆刚.“诸寒收引皆属于肾”对类风湿性关节炎治疗的指导价值[J].中华中医药学刊,2015,33(3):599-603.
[20] 王萌,张毅,李娟,等.“诸寒收引,皆属于肾”在《伤寒杂病论》中的应用浅析[J].新中医,2016,48(11):203-204.
[21] 陶帅,万长安,姜宏.基于数据挖掘的膝骨关节炎内服汤剂用药规律研究[J].山西中医,2022,38(7):52-55.
[22] 陶帅,姜宏,戴瑜,等.基于天癸理论的补肾活血方治疗绝经后膝骨关节炎的临床疗效观察[J].中国中医骨伤科杂志,2021,29(10):22-27.
[23] 赵宏建,刘双晶,李建朋,等.牛膝干预膝骨关节炎的代谢组学研究[J].中医学报,2024,39(5):1061-1067.
[24] 熊应宗,朱俊琛,王超,等.针刀联合塞来昔布治疗膝骨关节炎的临床疗效观察[J].中国中医骨伤科杂志,2020,28(2):19-23.
[25] 成俊明.肌骨超声观察浮针联合洪拳功法治疗膝骨关节炎临床研究[J].辽宁中医杂志,2022,49(11):76-79.
[26] KOSKI J,KAMEL A,WARIS P,et al.Atlas-based knee osteophyte assessment with ultrasonography and radiography:relationship to arthroscopic degeneration of articular cartilage[J].Scandinavian Journal of Rheumatology,2016,45(2):158-164.
[27] 沈高波,崔龙慷,张兵兵,等.骨痹饮治疗膝骨关节炎的临床疗效及对骨髓病变的影响[J].中国中医骨伤科杂志,2025,33(1):42-47.
[28] 夏雪,沈霖,凌家艳,等.加味阳和汤治疗寒湿痹阻型膝骨关节炎的疗效及对炎症因子的影响[J].中国中医骨伤科杂志,2024,32(3):55-58.
(收稿日期:2025-06-29)

备注/Memo

备注/Memo:
基金项目:江苏省中医药科技发展计划面上项目(MS2023149)
泰州市大健康产业创新能力提升(社会发展)非企项目(TS202313)
泰州市中医药科技项目(TZ202306)
通信作者 E-mail:taoshuai130@163.com
更新日期/Last Update: 2026-02-15